A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease Article

Full Text via DOI: 10.1158/1538-7445.AM2014-CT302 Web of Science: 000349910205069

Cited authors

  • Cowherd, Stacy; Melin, Susan; Akman, Steven; Cole, John; Lawrence, Julia


Publication date

  • 2014

Published in

International Standard Serial Number (ISSN)

  • 0008-5472


  • 74


  • 19